TABLE 1.
Estimated coverage* with the first and second dose of measles-containing vaccine (MCV), vaccination schedule,† number of reported measles cases,§ and measles cases per 1 million population,¶ by country — World Health Organization (WHO) South-East Asia Region, 2003 and 2013
| Country | 2003 | 2013 | 2003–2013 | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
|
|
||||||||||||
| WHO/UNICEF estimated coverage* (%) | MCV schedule† | No. of reported measles cases (JRF)§ | Measles incidence per million population¶ | WHO/UNICEF estimated coverage* (%) | MCV schedule† | No. of reported measles cases (JRF)§ | Measles incidence per million population¶ | % change in MCV1 coverage | % change in measles incidence per million population | |||||
|
|
|
|
|
|||||||||||
| MCV1 (%) | MCV2 (%) | MCV1 | MCV2 | MCV1 (%) | MCV2 (%) | MCV-1 | MCV2 | |||||||
| Bangladesh | 76 | —** | M-9 mos | —** | 4,067 | 30.6 | 93 | 81 | MR-9 mos | M-15 mos | 237 | 1.5 | 22 | −95 |
| Bhutan | 88 | —** | M-9 mos | —** | 0 | 00.0 | 94 | 89 | MR-9 mos | M-24 mos | 0 | 0.0 | 7 | 0 |
| North Korea | 95 | —** | M-9 mos | —** | 0 | 00.0 | 99 | 99 | M-9 mos | M-15 mos | 0 | 0.0 | 4 | 0 |
| India | 62 | —** | M-9 mos | —** | 47,147 | 44.0 | 74 | 42 | M-9 mos | M-16–24 mos | 13,822 | 11.1 | 19 | −75 |
| Indonesia | 74 | 21†† | M-9 mos | M-7 yrs†† | 24,457 | 114.4 | 84 | 79 | M-9 mos | M-6yrs§§ | 8,419 | 33.9 | 14 | −70 |
| Maldives | 96 | —** | M-9 mos | —** | 75 | 267.3 | 99 | 99 | M-9 mos | MMR-18 mos | 0 | — | 3 | −100 |
| Myanmar | 80 | —** | M-9 mos | —** | 830 | 15.6 | 86 | 80 | M-9 mos | M-18 mos | 1,010 | 16.2 | 8 | 4 |
| Nepal | 75 | —** | M-9 mos | —** | 13,344 | 537.8 | 88 | —** | MR-9 mos | —** | 1,861 | 68.3 | 17 | −87 |
| Sri Lanka | 99 | 90 | M-9–12 mos¶¶ | MR-3 yrs | 65 | 3.4 | 99 | 99 | MMR-1 yrs | MMR-3 yrs | 2,107 | 102.9 | 0 | 2,947 |
| Thailand | 96 | 92 | M-9 mos | MMR-6 yrs | 4,519 | 71.8 | 99 | 94 | MMR-9 mos | MMR-7 yrs | 2,641 | 40.7 | 3 | −43 |
| Timor-Leste | 55 | —** | M-9 mos | —** | 94 | 110.6 | 70 | —** | M-9 mos | —** | 4 | 3.4 | 27 | −97 |
| Region overall | 67 | 6 | 94,598 | 58.9 | 78 | 53 | 30,101 | 16.2 | 16 | −72 | ||||
Abbreviations: M = measles; MR = measles-rubella; MMR = measles-mumps-rubella; UNICEF = United Nations Children’s Fund; JRF = Joint Reporting Form.
Data were from WHO and UNICEF estimates, 2013 revision (as of July 2014). Data available at http://www.who.int/immunization/monitoring_surveillance/data/en.
As reported to WHO/UNICEF on JRFs for the year.
JRF was submitted to WHO and UNICEF by member states with the official immunization data and reports the number of measles cases in the country for the year.
Measles incidence was calculated based on the reported measles cases and population by member states through WHO/UNICEF JRF.
MCV2 was not introduced in routine immunization.
Subnational introduction in schools of West Java at age 7 years.
In a few selected provinces in Indonesia, MCV2 was given at age 24 months.
Changed in 2011 from age 9 months to 9–12 months.